Polymorphisms in the N acetyltransferase 1 NAT1 gene and lung cancer risk in a minority population
- PMID: 23899331
- DOI: 10.1080/135475098231237
Polymorphisms in the N acetyltransferase 1 NAT1 gene and lung cancer risk in a minority population
Abstract
One of the most consistently observed exposure-disease relationship is the one between cigarette smoking and lung cancer. Aromatic amines and their metabolites are found in tobacco smoke and may be a class of carcinogen involved in lung carcinogenesis. T he human N -acetyltransferase 1 (NAT 1) enzyme can activate or deactivate aromatic amines, making it a candidate genetic susceptibility gene. We evaluated the potential role of the NAT 1 gene in lung cancer risk in a hospital-based case-control study in a minority population composed of Mexican- and African-Americans. We also assessed the potential interaction between NAT 1 and other environmental exposures such as cigarette smoking. T here was no overall association between the NAT1*10 genotypes and lung cancer risk. T he adjusted odds ratio for the rapid acetylation genotypes was 0 72 (95 % CI 0 37-1 39) for NAT1 defined as the presence of at least one copy of the NAT1*10 allele when compared with all genotypes without the NAT1*10 allele. Analyses by histological subtype or smoking history did not alter these findings. Other NAT 1 alleles will need to be studied for more conclusive results regarding the relevance of NAT 1 activity to lung carcinogenesis.
Similar articles
-
Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):99-107. doi: 10.1158/1055-9965.EPI-05-0618. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16434594
-
Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.Br J Cancer. 1999 Oct;81(3):537-41. doi: 10.1038/sj.bjc.6690727. Br J Cancer. 1999. PMID: 10507782 Free PMC article.
-
Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.Cancer Epidemiol Biomarkers Prev. 1997 Apr;6(4):225-31. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9107426
-
Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):29-42. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10667461 Review.
-
Genetic polymorphism in N-Acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activity.J Toxicol Environ Health B Crit Rev. 2009;12(5-6):440-72. doi: 10.1080/10937400903158383. J Toxicol Environ Health B Crit Rev. 2009. PMID: 20183529 Review.
Cited by
-
NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.Int J Clin Exp Med. 2015 Jun 15;8(6):9177-91. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26309576 Free PMC article.
LinkOut - more resources
Full Text Sources